EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Oxidative protein damage and degradation in lymphocytes from patients infected with human immunodeficiency virus


Journal of Infectious Diseases 176(3): 655-664
Oxidative protein damage and degradation in lymphocytes from patients infected with human immunodeficiency virus
It has been proposed that oxidative stress is the common mediator of apoptotic cell death in AIDS. However, mechanistic relationships between oxidative damage and cell death are far from clear. It is reported here that the mitogenic activation of T lymphocytes from human immunodeficiency virus-positive subjects involves perturbation of redox balance, as indicated by the increase in hydroethydine intracellular oxidation and manganese superoxide dismutase adaptive induction. Principal molecular targets of oxidative injury are cellular proteins whose content in carbonyl groups increases together with a dramatic increase in degradation of newly synthesized proteins catalyzed by the ATP- and ubiquitin-dependent proteolytic system. The major consequence of this metabolic anomaly is the decrease in protein cell mass leading to cells that are smaller than normal at lethal mitosis.


Accession: 002914128

PMID: 9291312

DOI: 10.1086/514087



Related references

Epstein-Barr virus-infected lymphocytes in non-neoplastic lymph nodes of patients infected with human immunodeficiency virus. Pathology International 47(4): 217-221, 1997

Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. Journal of Virology 77(8): 4938-4949, 2003

Tryptophan degradation in patients infected by human immunodeficiency virus. Biological Chemistry Hoppe-Seyler 369(5): 337-340, 1988

Polyamines in lymphocytes from patients infected by human immunodeficiency virus. Biological Chemistry Hoppe-Seyler 370(7): 745-748, 1989

Lymphocytes in the lungs of human immunodeficiency virus infected patients. Chest 98(2 SUPPL): 51S, 1990

Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology 208(2): 770-775, 1995

The frequency, activation, and coreceptor expression of lymphocytes in human immunodeficiency virus/hepatitis C virus co-infected patients in China. Japanese Journal of Infectious Diseases 62(4): 284-288, 2009

Changes of purine nucleotide content in lymphocytes from patients infected with human immunodeficiency virus. Advances in Experimental Medicine and Biology 370: 453-458, 1994

CD4+ lymphocytes and opportunistic infections and neoplasms in patients infected with the human immunodeficiency virus. Medicina Clinica 103(19): 758; Author Reply 759-758; Author Reply 759, 1994

Quality of life among human immunodeficiency virus-1 infected and human immunodeficiency virus-1/hepatitis C virus co-infected individuals in Iranian patients. Nigerian Medical Journal 57(1): 49-53, 2016